文献速递生殖医学产科母胎医学

薄型子宫内膜胚胎移植后的妊娠并发症与胎盘组织学

Pregnancy complications and placental histology following embryo transfer with a thinner endometrium.
PubMed 文献 · Hum Reprod · 2022-01-01

这项2009至2017年的回顾性队列研究纳入1057例IVF后单胎活产分娩,比较子宫内膜<9 mm组(292例)与≥9 mm组(765例)。

要点

  • 薄型子宫内膜组胎盘介导主要并发症22.9%,对照组15.2%(P=0.003)。
  • 薄型子宫内膜组胎盘变薄、双叶胎盘及母体灌注不良病变发生率更高。

核心结论

  • 薄型子宫内膜IVF活产与胎盘介导产科并发症发生率升高及出生体重降低相关,胎盘呈现大体解剖和组织学灌注不良病变。

研究设计与样本

  • 回顾性队列研究,纳入2009至2017年一家三级大学医院IVF后单胎活产分娩共1057例。
  • 按胚胎移植时子宫内膜厚度分为<9 mm组(292例)与≥9 mm组(对照组,765例)。
  • 按本院方案所有胎盘无论有无妊娠并发症均送病理检查,胎盘病变按阿姆斯特丹胎盘工作组共识分类。

主要发现

  • 两组母体人口学特征无显著差异,仅主要不孕指征中卵巢储备减退在薄型子宫内膜组更常见、男性因素更少见(P=0.003)。
  • 对照组新鲜移植率更高,薄型子宫内膜组囊胚移植率更高。
  • 调整混杂因素后,薄型子宫内膜组胎盘介导主要并发症总体发生率22.9%,对照组15.2%(P=0.003)。
  • 薄型子宫内膜组胎盘厚度减小、双叶胎盘发生率更高,母体灌注不良病变发生率更高。

关键数值与推荐

  • 子宫内膜薄型定义为胚胎移植时内膜厚度<9 mm,对照为≥9 mm。

临床怎么用

  • 作者认为,在计划以较薄子宫内膜进行胚胎移植时,应考虑其过高的产科风险。
  • 作者指出,需进一步研究评估周期取消的收益以及米屈肼(Micropirin)等潜在预防措施的效果。

局限性

  • 研究受回顾性设计限制。
  • 缺乏既往子宫手术相关数据。
  • 样本量有限,不足以检测较少见结局的差异,也不足以按更严格的薄型子宫内膜定义进行分析。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Are deliveries following IVF with a thinner endometrium associated with adverse perinatal outcomes and placental findings? SUMMARY ANSWER: Live births following IVF with a thinner endometrium are associated with an increased rate of placental-mediated obstetric complications and lower birthweight, while the placentas are notable for gross anatomical and histological malperfusion lesions. WHAT IS KNOWN ALREADY: Past studies have noted a higher rate of adverse outcomes on deliveries following IVF with a thinner endometrium, mainly placental-associated complications. However, no study to date has investigated placental histopathology in such cases. STUDY DESIGN, SIZE, DURATION: This was a retrospective cohort study of 1057 deliveries following IVF, between 2009 and 2017. All placentas were sent to pathology irrelevant of pregnancy complication status, per protocol at our institution. PARTICIPANTS/MATERIALS, SETTING, METHODS: Live singleton births from a tertiary university hospital after IVF were compared between patients for whom embryo transfer was performed with an endometrium <9 mm (thinner endometrium group) and patients with an endometrium ≥9 mm (control group). Placental pathologic findings were categorized according to the Amsterdam Placental Workshop Group Consensus. Outcomes were placental findings, including anatomic, inflammatory, vascular malperfusion and villous maturation lesions, as well as obstetric and perinatal outcomes. Continuous and categorical variables were compared as appropriate, and multivariate regression and linear analyses were employed to control for confounders. MAIN RESULTS AND THE ROLE OF CHANCE: A total 292 cases in the thinner endometrium group, and 765 in the control group were compared. Maternal demographics were non-significant between the groups, except for main fertility indication was more commonly diminished reserve in patients with a thinner endometrium and less commonly male factor, P = 0.003. Higher rates of fresh transfers were noted in the control group, while the thinner endometrium group was notable for higher rates of blastocyte transfers. After adjustment for confounders, deliveries in the thinner endometrium group were associated with an overall higher rate of main placental-mediated complications, 22.9% versus 15.2%, P = 0.003, and significantly lower birthweight, β -100.76 g (-184.4-(-17.0)). Placentas in the thinner endometrium group were notable for reduced thickness and a higher rate of bilobated placentas. Placental histology in the thinner endometrium group demonstrated a higher rate of maternal malperfusion lesions. LIMITATIONS, REASONS FOR CAUTION: The study was limited by its retrospective design and lack of data regarding prior uterine surgery. In addition, sample size was limited for detection of differences in outcomes of rarer occurrence and for analysis as per a stricter definition of thin endometrium. WIDER IMPLICATIONS OF THE FINDINGS: Excess obstetric risks should be taken into consideration while planning an embryo transfer with a thinner endometrium. Further studies are needed to assess the yield of cycle cancellation and the effect of potential preventive measures such as Micropirin treatment. STUDY FUNDING/COMPETING INTEREST(S): No funding was used and the authors report no conflicting interests. TRIAL REGISTRATION NUMBER: N/A.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Ganer Herman H, Volodarsky-Perel A, Ton Nu TN, et al. Pregnancy complications and placental histology following embryo transfer with a thinner endometrium. Hum Reprod. 2022. PMID: 35771669. doi:10.1093/humrep/deac148

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。